Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07245628 · ClinicalTrials.gov registry record · Early Phase 1

A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy

A Early Phase 1 study of Vasectomy, sponsored by Alexandra J. Berger Eberhardt, MD.

Recruiting
Registry status
Early Phase 1
Development phase
50
Enrollment target
1
Study location

NCT07245628 is a Early Phase 1 study of Vasectomy that is actively recruiting participants, run by Alexandra J. Berger Eberhardt, MD. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07245628, a Early Phase 1 study of Vasectomy, is actively recruiting participants, sponsored by Alexandra J. Berger Eberhardt, MD.

RECRUITING
Registry status
Early Phase 1
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to see if nitrous oxide is safe and effective to use during during vasectomies performed in a clinic/in-office setting. This trial will compare self-administered nitrous oxide versus a placebo (oxygen) during office vasectomy. The main questions it aims to answer are: * Whether self-administered low dose (20-45%) nitrous oxide (SANO) reduces intraoperative anxiety and catastrophizing during office vasectomy. * To examine whether SANO reduces intraoperative pain or alters procedure duration, the rate of adverse events, or urologists' perception of ease and patient tolerance of the procedure. Participants will be asked to complete multiple surveys pre-procedure, intra-procedure, and post-procedure.

Conditions Studied

Interventions

  • DRUG Oxygen
  • DRUG Nitrous Oxide

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-10-20
Est. Completion 2030-05-01
Phase Early Phase 1

What the Registry Record Tells You About NCT07245628

The ClinicalTrials.gov registry entry for NCT07245628 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexandra J. Berger Eberhardt, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vasectomy appearing as the primary indexed condition, and to 2 interventions - of which Oxygen is the first listed.

NCT07245628 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07245628 about?

NCT07245628 is a clinical study titled "A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy". The goal of this clinical trial is to see if nitrous oxide is safe and effective to use during during vasectomies performed in a clinic/in-office setting. This trial will compare self-administered nitrous oxide versus a placebo (oxygen) during office vasectomy. The main questions it aims to answer...

What is the current status of trial NCT07245628?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2025-10-20. Estimated completion is 2030-05-01.

What conditions does trial NCT07245628 study?

This clinical trial studies the following conditions: Vasectomy.

What interventions are being tested in trial NCT07245628?

The interventions under investigation include: Oxygen (DRUG), Nitrous Oxide (DRUG).

Who is sponsoring clinical trial NCT07245628?

This trial is sponsored by Alexandra J. Berger Eberhardt, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07245628 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vasectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.